In epidemiological studies, patients with prediabetes or type 2 diabetes exhibited elevated systemic galectin-3, which correlates inversely with glycosylated hemoglobin [8] and positively with insulin sensitivity [9], supporting that galectin-3 is more likely to be an alternative biomarker in the progression of diabetes. Here, LGALS3 is linked to diabetes mellitus.